Astrazeneca (AZN) Congress Trading Statistics 2025

$16,000

Est. value of AZN Stock Transactions by US Politicians Over the Past 2 Years.

Similar companies

Company		Est. Transaction Value
	Pfizer PFE	-$8,500
	Johnson & Johnson JNJ	-$240,000
	Moderna MRNA	$24,000
	AbbVie ABBV	$130,000
	Eli Lilly and Company LLY	-$230,000

Trades by US Politicians

Politician	Filing Date	Type	Size
Val Hoyle	Sep 23, 2025	Sell	$1K - $15K
Lisa McClain	Jul 22, 2025	Buy	$1K - $15K
Lisa McClain	Jun 9, 2025	Buy	$1K - $15K
Bruce Westerman	Apr 21, 2025	Sell	$1K - $15K
Bruce Westerman	Mar 3, 2025	Buy	$1K - $15K
Valerie Hoyle	Oct 29, 2024	Buy	$1K - $15K

Who is the latest politician to buy or sell Astrazeneca shares?

Val Hoyle sold Astrazeneca shares most recently on September 23, 2025.

Which politician has bought the most AZN stock in the last two years?

Lisa McClain has bought the most AZN stock in the last 2 years, with an estimated value of $16,000.

Which politician has sold the most AZN stock over the last two years?

Bruce Westerman has sold the most AZN stock in the last 2 years, with an estimated value of $8,000.

What is the total value of politicians trading AZN stock in the last 2 years?

According to our estimates, the net value of trades by US politicians for Astrazeneca in the last 2 years is positive, amounting to $16,000. This indicates that US politicians have reasons to believe that the stock is going to go up.

How do insider transactions over the last 2 years reflect on Astrazeneca's market confidence?

Over the last 2 years, insider transactions for Astrazeneca have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.

Why should individual investors pay attention to the stock transactions of US politicians?

Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.